Evidence map›Paper›PMID 31594848›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Sustained ER stress promotes hyperglycemia by increasing glucagon action through the deubiquitinating enzyme USP14.

Bin Liu, Zhijian Zhang, Yanyun Hu, Yan Lu, Duanzhuo Li, Jie Liu, Shengjie Liao, Min Hu, Yuxing Wang, Die Zhang and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Bin LiuDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, 20032 Shanghai, People's Republic of China.
Zhijian ZhangDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 201620 Shanghai, People's Republic of China.
Yanyun HuDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 201620 Shanghai, People's Republic of China.
Yan LuDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, 20032 Shanghai, People's Republic of China.
Duanzhuo LiHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Jie LiuHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Shengjie LiaoHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Min HuHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Yuxing WangHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Die ZhangHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Yulu ChenHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Qilan QianHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Xianfeng LvHubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University School of Medicine, 435003 Huangshi, Hubei, People's Republic of China.
Duojiao WuZhongshan Hospital Institute of Clinical Science, Fudan University Medical School, 200032 Shanghai, People's Republic of China.
Minjia TanState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203 Shanghai, People's Republic of China.
Cheng HuShanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Centre for Diabetes, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 200233 Shanghai, People's Republic of China.
Xuelian XiongDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, 20032 Shanghai, People's Republic of China; xiong.xuelian@zs-hospital.sh.cn li.xiaoying@zs-hospital.sh.cn.
Xiaoying LiDepartment of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, 20032 Shanghai, People's Republic of China; xiong.xuelian@zs-hospital.sh.cn li.xiaoying@zs-hospital.sh.cn.
Hubei Polytechnic University · CNSun Yat-sen University · CNShanghai Jiao Tong University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endoplasmic reticulum (ER) stress plays an important role in metabolic diseases like obesity and type 2 diabetes mellitus (T2DM), although the underlying mechanisms and regulatory pathways remain to be elucidated. Here, we induced chronic low-grade ER stress in lean mice to levels similar to those in high-fat diet (HFD)-fed obese mice and found that it promoted hyperglycemia due to enhanced hepatic gluconeogenesis. Mechanistically, sustained ER stress up-regulated the deubiquitinating enzyme ubiquitin-specific peptidase 14 (USP14), which increased the stability and levels of 3',5'-cyclic monophosphate-responsive element binding (CREB) protein (CBP) to enhance glucagon action and hepatic gluconeogenesis. Exogenous overexpression of USP14 in the liver significantly increased hepatic glucose output. Consistent with this, liver-specific knockdown of USP14 abrogated the effects of ER stress on glucose metabolism, and also improved hyperglycemia and glucose intolerance in obese mice. In conclusion, our findings show a mechanism underlying ER stress-induced disruption of glucose homeostasis, and present USP14 as a potential therapeutic target against T2DM.

Indexed as

AnimalsDiabetes Mellitus, Type 2Diet, High-FatEndoplasmic ReticulumEndoplasmic Reticulum StressGene Knockdown TechniquesGlucagonGluconeogenesisGlucoseGlucose IntoleranceHyperglycemiaMiceMice, Inbred C57BLMice, ObeseObesityUbiquitin ThiolesteraseGlucagonGlucoseUbiquitin ThiolesteraseUsp14 protein, mouseER stressgluconeogenesishepatic glucose productiontype 2 diabetesUSP14

Identifiers

PMID31594848
PMCPMC6815134
OpenAlexW2980033472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.